Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation
Mohd P. Khan, … , Deanne Taylor, Ernestina Schipani
Mohd P. Khan, … , Deanne Taylor, Ernestina Schipani
Published August 1, 2024
Citation Information: JCI Insight. 2024;9(18):e182330. https://doi.org/10.1172/jci.insight.182330.
View: Text | PDF
Research Article Bone biology

HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation

  • Text
  • PDF
Abstract

Energy metabolism, through pathways such as oxidative phosphorylation (OxPhos) and glycolysis, plays a pivotal role in cellular differentiation and function. Our study investigates the impact of OxPhos disruption in cortical bone development by deleting mitochondrial transcription factor A (TFAM). TFAM controls OxPhos by regulating the transcription of mitochondrial genes. The cortical bone, constituting the long bones’ rigid shell, is sheathed by the periosteum, a connective tissue layer populated with skeletal progenitors that spawn osteoblasts, the bone-forming cells. TFAM-deficient mice presented with thinner cortical bone, spontaneous midshaft fractures, and compromised periosteal cell bioenergetics, characterized by reduced ATP levels. Additionally, they exhibited an enlarged periosteal progenitor cell pool with impaired osteoblast differentiation. Increasing hypoxia-inducible factor 1a (HIF1) activity within periosteal cells substantially mitigated the detrimental effects induced by TFAM deletion. HIF1 is known to promote glycolysis in all cell types. Our findings underscore the indispensability of OxPhos for the proper accrual of cortical bone mass and indicate a compensatory mechanism between OxPhos and glycolysis in periosteal cells. The study opens new avenues for understanding the relationship between energy metabolism and skeletal health and suggests that modulating bioenergetic pathways may provide a therapeutic avenue for conditions characterized by bone fragility.

Authors

Mohd P. Khan, Elena Sabini, Katherine Beigel, Giulia Lanzolla, Brittany Laslow, Dian Wang, Christophe Merceron, Amato Giaccia, Fanxin Long, Deanne Taylor, Ernestina Schipani

×

Figure 4

Loss of TFAM reduces steady-state intracellular ATP levels in periosteal cells.

Options: View larger image (or click on image) Download as PowerPoint
Loss of TFAM reduces steady-state intracellular ATP levels in periosteal...
(A) Quantitative analysis of ATP concentrations in cultured periosteal cells selected by FACS for tdTomato expression. ATP levels were compared among 3 groups: TFAMfl/fl Ai14fl/+ (CTRL), PRX TFAMfl/+ Ai14fl/+ (Het-TFAM Ai14), and PRX TFAMfl/fl Ai14fl/+ (TFAM Ai14) periosteal cells. (B) Quantification of the efficiency of TFAM-floxed allele recombination. (C) Quantification of mitochondrial genes by qPCR in CTRL and TFAM periosteal cells, focusing on cytochrome C oxidase 3 (Cox3), cytochrome B (Cytb), and 16S ribosomal RNA (16S rRNA) genes. Biological duplicates and technical duplicates or triplicates were used in experiments. Statistical significance was assessed using 1-way ANOVA with a Bonferroni post hoc test for comparisons among the 3 groups and an independent Student’s 2-tailed t test for pairwise comparisons. Data are presented as mean ± SD and normalized to CTRL levels to accommodate experimental variability. Significance levels are indicated as **P ≤ 0.01 and ***P ≤ 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts